Voice changes following androgenic hormone treatment in women

article OA: closed CC0
View on OpenAlex View at publisher
AI-generated summary by claude@2026-06, 2026-06-07

This study found minimal objective vocal changes in ten women treated with Danazol, indicating a need for individualized voice assessments when prescribing androgenic hormones.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Androgenic medications have been known to cause changes to the vocal folds and to voice quality for many decades. One such androgen is Danazol, a synthetic derivative of testosterone. Although altered perceptual voice features have been consistently reported following treatment with Danazol, objective measurements of the voice changes have been limited. The current study incorporates a comprehensive assessment battery of vocal function including instrumental techniques, acoustic analysis and perceptual voice assessment, carried out before, during and after treatment with Danazol in a group of 10 women. The results failed to indicate significant changes in the majority of voice parameters studied. Owing to the variability found in the group results it was clear that the vocal function of women prescribed androgenic hormones needs to be assessed on an individual basis.

My notes (saved in your browser only)

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (45)

Source provenance

crossref
last seen: 2026-05-10T19:04:07.457109+00:00
openalex
last seen: 2026-05-10T10:26:51.820283+00:00
unpaywall
last seen: 2026-06-02T02:00:03.124865+00:00
License: CC0 · commercial use OK